Ted Goldthorpe
Mr. Goldthorpe was also appointed as the chair of the Board, effective March 21, 2025.
Highest-materiality recent filing
Runway Growth Finance reduces credit facility from $550M to $425M, waives prior defaults
Credit facility commitment reduced from $550M to $425M effective June 30, 2026.
Runway Growth adviser/affiliates commit to buy up to 10% of common stock; Q2 originations $85.8M
Adviser and affiliates commit to purchase up to 10% of outstanding common stock over 24 months if shares trade below 70% of NAV ($8.49).
Runway Growth Q1 2026 NII $10.6M ($0.29), NAV $12.13; $0.33 dividend, $15M buyback, CFO retirement
NII $10.6M ($0.29 per share) vs $15.6M ($0.42) Q1 2025; total investment income $29.5M vs $35.4M.
Runway Growth closes SWK acquisition for $249M; Q1 portfolio update, Spreng returns as CIO
Acquired SWK Holdings for $249M: $75.5M in RWAY shares at $11.93 NAV and $173.5M cash; adviser contributed additional $9M.
Runway Growth Q4 NII $0.32/sh; NAV $13.42; proposes acquisition of SWK holdings
Q4 2025 total investment income $30.0M vs $33.8M YoY; NII $11.6M ($0.32/sh) vs $14.6M ($0.39/sh).
Runway Growth issues $103.25M of 7.25% notes due 2031; redeems $92M of higher-coupon notes
New $103.25M 7.25% Notes due 2031 issued; interest paid quarterly, maturity Feb 3, 2031.
Runway Growth Finance issues $100M of 7.25% notes due 2031
Issued $100M aggregate principal of 7.25% Notes due 2031; closing expected Feb 3, 2026.
FTC grants early HSR termination for Runway Growth-SWK merger
FTC granted early HSR waiting period termination effective Dec 2, 2025, for SWK Holdings merger into RWAY.
Runway Growth Q3 NII $0.43/sh flat YoY; announces SWK Holdings merger
Q3 2025 net investment income $15.7M ($0.43/sh) vs $15.9M ($0.41) YoY; total investment income flat at $36.7M.
Runway Growth Finance acquires SWK Holdings via stock/cash merger with key stockholder support
SWK stockholders may elect RWAY common stock (NAV-based exchange ratio) or cash equal to SWK per-share NAV.
Runway Growth funds $128.3M in Q3 2025; receives $201.2M in repayments
Funded 11 investments totaling $128.3M in Q3, including new deals with FHAS ($10M) and Digicert ($10M).
Runway Growth to acquire SWK Holdings for ~$220M in NAV-for-NAV merger
Estimated purchase price ~$220M: $75.5M in RWAY shares + ~$145M cash + $9M from advisor.
Runway Growth Q2 2025: NII $13.9M ($0.38/sh), NAV $13.66, yield 15.4%
Total investment income $35.1M; net investment income $13.9M ($0.38/sh) vs $14.6M ($0.37/sh) a year ago.
Runway Growth Q1 NII $15.6M ($0.42/sh); $0.35 dividend; $25M buyback
Total investment income $35.4M, down from $40.0M YoY; NII $15.6M ($0.42/sh) vs. $18.7M ($0.46/sh).
Runway Growth issues $107M 7.51% senior notes due 2028 in private placement
Issued $107M aggregate principal amount of 7.51% Series 2025A Senior Notes due April 7, 2028; fixed rate 7.51%.
Runway Growth Q4 NII $14.6M ($0.39/sh); NAV $13.79; declares $0.36 dividend
Total investment income $33.8M, down from $39.2M YoY; NII $14.6M ($0.39/sh) vs $18.3M ($0.45/sh).
Runway Growth Capital closes acquisition by BC Partners Credit and Mount Logan Capital
New advisory agreement effective Jan 30, 2025, with same fee structure and services as prior agreement.
Runway Growth Q3 NII $0.41/share; NAV $13.39; $0.40 dividend; adviser sale to BC Partners
Total investment income $36.7M, net investment income $15.9M ($0.41/share) vs $22.0M ($0.54) year ago.
BC Partners Credit will acquire Runway Growth Capital, external adviser to BDC Runway Growth Finance (RWAY), closing expected Q4 2024.
Runway Growth Q2 NII falls to $0.37/share from $0.49; NAV drops to $13.14
Total investment income $34.2M, down 18% from $41.9M YoY.
Runway Growth Q2 2024 portfolio: $75.5M funded, $25.3M prepayment
Funded $58.4M to a marketing tech SaaS platform for customer engagement and $17.1M to Onward Medical (spinal cord stimulation therapy).
Selling stockholder OCM Growth Holdings offers 3.75M shares of Runway Growth common stock
Underwriting agreement for secondary offering of 3,750,000 shares by Selling Stockholder OCM Growth Holdings LLC.
Runway Growth Q1 NII $18.7M ($0.46/sh), CEO Spreng returns from leave, Q2 div $0.47
Total investment income $40.0M, NII $18.7M ($0.46/sh) vs $18.2M ($0.45/sh) YoY.
Runway Growth Q4 total investment income $39.2M, NII $0.45/share; NAV drops to $13.50
Total investment income Q4 $39.2M (up from $36.5M YoY); net investment income $18.3M ($0.45/share, flat YoY).
Runway Growth forms $200M joint venture with Cadma Capital Partners (Apollo affiliate)
Runway-Cadma I LLC will be an equal partnership between Runway and Cadma.
Runway Growth Finance Corp. expands credit facility to $550M, accordion to $600M
Increased facility amount from $500M to $550M via new lender joinder.
Runway Growth Finance Corp. discloses secondary offering of 3.75M shares by OCM and Oaktree
Underwriting agreement dated Nov 13, 2023 for sale of 3,750,000 shares by selling stockholders OCM Growth Holdings and Oaktree Opportunities Fund XB Holdings.
Runway Growth Q3 NII $22.0M ($0.54/sh); declares $0.46 total dividend; approves $25M buyback
Total investment income $43.8M; net investment income $22.0M, or $0.54 per share, up from $0.36 YoY.
Mr. Goldthorpe was also appointed as the chair of the Board, effective March 21, 2025.
On March 13, 2025, the Board elected Jennifer Kwon Chou as an independent director, effective March 21, 2025, to fill the vacancy created by Mr. Engel’s resignation.
By correspondence dated March 13, 2025, John Engel informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company, effective March 21, 2025
On March 13, 2025, the Board also elected Robert Warshauer and Alexander Duka as independent directors, and Ted Goldthorpe as an interested director, each effective March 21, 2025, to fill the vacancies created in connection with the Board’s decision to increase the size of the Board from five directors to eight directors.
On March 13, 2025, the Board also elected Robert Warshauer and Alexander Duka as independent directors, and Ted Goldthorpe as an interested director, each effective March 21, 2025, to fill the vacancies created in connection with the Board’s decision to increase the size of the Board from five directors to eight directors.
On November 15, 2024, Gregory M. Share informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company.
On August 18, 2023, the Board elected Gregory M. Share as a director, effective immediately, to fill the vacancy created by Mr. Laibow’s resignation.
On July 31, 2023, Board of Directors (the “Board”) appointed Thomas B. Raterman to temporarily serve as Acting President of the Company, effective immediately.
R. David Spreng, the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, will be taking a temporary leave of absence from the Company in order to undergo treatment for a medical condition.
On July 31, 2023, the Board also appointed Greg Greifeld, the Managing Director, Deputy Chief Investment Officer and Head of Credit at Runway Growth Credit, LLC, (“Runway”), the Company’s investment adviser, to temporarily serve as Acting Chief Executive Officer of the Company, effective immediately.
on July 31, 2023, Julie Persily, an independent director and Chair of the Audit Committee of the Board, was appointed by the Board as Acting Chairperson of the Board and Lead Independent Director.
On July 10, 2023, Brian Laibow informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as director of the Company, effective upon the appointment by the Board of another nominee by OCM Growth Holdings, LLC (“OCM”) in accordance with the Stockholder Agreement between the Company and OCM, dated December 15, 2016.
Max materiality 0.85 · Median 0.60 · Most common event other_material